Table I.
Number (%) | PEP | ||
---|---|---|---|
All patients | 1334 | 115 (8.6%) | |
Mean age ± SD (years) | 65.5 ± 12.7 | ||
Sex | Male | 857 (64.2%) | 72 (8.4%) |
Female | 477 (35.8%) | 43 (9.0%) | |
| |||
Previous PEP | Presence | 81(6.1%) | 36 (44.4%) |
Absence | 1253(93.9%) | 79 (6.3%) | |
| |||
Previous acute pancreatitis | Presence | 52(3.9%) | 17 (52.7%) |
Absence | 1282(96.1%) | 98 (7.6%) | |
| |||
Suspected SOD | Presence | 24 (1.8%) | 8 (33.3%) |
Absence | 1310 (98.2%) | 107 (8.2%) | |
| |||
Cannulation time | < 15 min | 992 (74.4%) | 70 (7.1%) |
≥ 15 min | 342 (25.6%) | 45 (13.2%) | |
| |||
Total procedure time | < 30 min | 464 (34.8%) | 28 (6.0%) |
≥ 30 min | 870 (65.2%) | 87 (10.0%) | |
| |||
EST | Performed | 175 (13.1%) | 20 (11.4%) |
Not performed | 1159 (86.9%) | 95 (8.2%) | |
| |||
Precut sphincterotomy | Performed | 18 (1.4%) | 0 (0%) |
Not performed | 1316 (98.6%) | 115 (8.7%) | |
| |||
Pancreatic duct injection | Performed | 923 (69.2%) | 92 (10.0%) |
Not performed | 411 (30.8%) | 23 (5.6%) | |
| |||
Pancreatic duct IDUS | Performed | 75 (5.6%) | 9 (12%) |
Not performed | 1259 (94.4%) | 106 (8.4%) | |
| |||
Bile duct IDUS | Performed | 120 (9.0%) | 13 (10.8%) |
Not performed | 1214 (91.0%) | 102 (8.4%) | |
| |||
Pancreatic duct aspiration cytology | Performed | 147 (11.0%) | 14 (9.5%) |
Not performed | 1187 (89.0%) | 101 (8.5%) | |
| |||
Bile duct aspiration cytology | Performed | 79 (5.9%) | 10 (12.7%) |
Not performed | 1255 (94.1%) | 105 (8.4%) | |
| |||
Pancreatic duct brush cytology | Performed | 108 (8.1%) | 18 (16.7%) |
Not performed | 1226 (91.9%) | 97 (7.9%) | |
| |||
Bile duct brush cytology | Performed | 146 (10.9%) | 16 (11.0%) |
Not performed | 1188 (89.1%) | 99 (9.1%) | |
| |||
Endoscopic pancreatic stenting | Performed | 131(9.8%) | 9 (6.9%) |
Not Performed | 1203 (90.2%) | 106 (8.8%) |
EPS: Endoscopic pancreatic stenting; ERCP: endoscopic retrograde cholangiopancreatography; EST: endoscopic sphincterotomy; IDUS: intraductal ultrasonography; SOD: sphincter of Oddi dysfunction.